With President Donald Trump handing out tariffs like Oprah and inflation coming in worse than expected, the market’s ...

In a report released today, Richard Anderson from Wedbush reiterated a Buy rating on RH (RH – Research Report), with a price target of $500.00.

Wedbush boosted their FY2029 earnings estimates for shares of Rezolute in a report released on Thursday, February 13th.

Equities research analysts at Wedbush lowered their Q1 2025 EPS estimates for shares of Airbnb in a research report issued to ...

Wedbush analyst Daniel Ives remains highly bullish on Tesla (TSLA) stock despite the concerns surrounding CEO Elon Musk’s ...

Dan Ives, Wedbush Securities global head of technology research, joins 'The Exchange' to discuss Ives' thoughts on Tesla, the ...

Wedbush raised the firm’s price target on SpringWorks Therapeutics (SWTX) to $81 from $77 and keeps an Outperform rating on the shares following the Food and Drug Administration’s approval for ...

Welltower (NYSE:WELL) was upgraded at Wedbush after the senior housing REIT "impressed with the growth outlook for 2025". The healthcare REIT turned in Q4 earnings and revenue that topped Wall ...

Wedbush highlights Palantir and Salesforce as top AI investments, predicting rapid enterprise adoption and major capital ...

Wedbush Securities, a leading financial services and investment firm, is proud to announce the launch of fast and efficient services for easy-to-borrow, locates and hard-to-borrow securities.

But now there is one analyst who’s again projecting upside: Wedbush’s Daniel Ives boosted his target price to $90 on Thursday morning. Palantir’s stock PLTR closed at $76.87 on Wednesday ...

Investing.com -- Apple's (NASDAQ: AAPL) partnership with Alibaba (NYSE: BABA) as part of its China AI strategy marks “a big ...